US Patent 7105489 Methods and compositions for treating polycystic ovary syndrome
Patent 7105489 was granted and assigned to Amylin Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
David R. Hathaway0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+190 characters)
Article
Patent abstract
The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1) to subjects suffering therefrom.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07105489 Methods and compositions for treating polycystic ovary syndrome US Patent 7105489 Methods and compositions for treating polycystic ovary syndrome
Infobox
Patent Number
071054890
Patent Number
71054890
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071054890
Date of Patent
September 12, 2006
0Patent Application Number
103171260
Date Filed
December 11, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07105489 Methods and compositions for treating polycystic ovary syndrome
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07105489
Date of patent
September 12, 2006
Patent application number
10317126
Date Filed
December 11, 2002
Patent primary examiner
Find more entities like US Patent 7105489 Methods and compositions for treating polycystic ovary syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
